AnodyneWiki

Ketoprofen

Ketoprofen
Ketoprofen
Salts
[]
Potassium ketoprofen
Potassium ketoprofen
Sodium ketoprofen
Sodium ketoprofen
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass254.28 g/mol [1]
Melting point94 °C [1]
Solubility51 mg/L (at 22 °C) [1]
Predicted LogP3.1 [1]
Structural Identifiers
[]
Molecular formulaC16H14O3
IUPAC name2-(3-benzoylphenyl)propanoic acid
SMILESCC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
InChIInChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)
InChIKeyDKYWVDODHFEZIM-UHFFFAOYSA-N
CAS number22071-15-4
UNII90Y4QC304K
PubChem CID3825
Pharmacokinetics[]
Elimination half-life2–2.5 hours
Routes of administrationBy mouth, topical, intravenous

Ketoprofen (also known as 2-(3-Benzoylphenyl)propionic acid, Orudis, Capisten, Oruvail, Actron, Alrheumat, Ketoprofene, Aneol, m-Benzoylhydratropic acid or 3-Benzoylhydratropic acid) is a nonsteroidal anti-inflammatory drug substance of the carboxylic acid class.

Chemistry

Salts []

Ketoprofen is typically found in the form of its potassium and sodium salts.

 []

Ketoprofen is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

Ketoprofen matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target15
shared target14

Medical side effects []

145 side effects listed on drug labels in (ketoprofen).

  • Dyspepsia
  • Arrhythmia
  • Colitis ulcerative
  • Proctocolitis
  • Diabetes mellitus
  • Gynaecomastia
  • Hallucination
  • Meningitis aseptic
  • Myocardial infarction
  • Acute coronary syndrome
  • Necrosis
  • Nightmare
  • Pancreatitis
  • Personality disorder
  • Sepsis
  • Shock
  • Dysphoria
  • Abdominal pain
  • Stomach ache
  • Gastrointestinal pain
  • Agranulocytosis
  • Alopecia
  • Amnesia
  • Anaphylactic shock
  • Anaemia
  • Aplastic anaemia
  • Angioedema
  • Decreased appetite
  • Anxiety
  • Asthma
  • Asthmatic attack
  • Bronchospasm
  • Colitis
  • Infection
  • Confusional state
  • Feeling abnormal
  • Malaise
  • Conjunctivitis
  • Constipation
  • Crohn's disease
  • Dermatitis exfoliative
  • Diarrhoea
  • Dizziness
  • Somnolence
  • Dysgeusia
  • Dyspnoea
  • Eczema
  • Oedema
  • Toxic epidermal necrolysis
  • Epistaxis
  • Eructation
  • Erythema multiforme
  • Stevens-Johnson syndrome
  • Dermatitis
  • Rash
  • Asthenia
  • Fatigue
  • Flatulence
  • Flushing
  • Gastritis
  • Gastrointestinal haemorrhage
  • Glossodynia
  • Headache
  • Cardiac failure
  • Cardiac failure congestive
  • Haematemesis
  • Haematuria
  • Haemolysis
  • Haemoptysis
  • Hepatitis
  • Hypersensitivity
  • Hypertension
  • Hyponatraemia
  • Jaundice
  • Laryngeal oedema
  • Melaena
  • Nausea
  • Tubulointerstitial nephritis
  • Nephrotic syndrome
  • Nervousness
  • Tension
  • Palpitations
  • Paraesthesia
  • Peptic ulcer
  • Pharyngitis
  • Pruritus
  • Purpura
  • Purpuric rash
  • Vascular purpura
  • Renal failure
  • Renal impairment
  • Retinal haemorrhage
  • Rhinitis
  • Salivary hypersecretion
  • Convulsion
  • Stomatitis
  • Mouth ulceration
  • Hyperhidrosis
  • Tachycardia
  • Thirst
  • Thrombocytopenia
  • Tinnitus
  • Urticaria
  • Vasodilation procedure
  • Vertigo
  • Vomiting
  • Weight increased
  • Weight decreased
  • Dry mouth
  • Peripheral vascular disorder
  • Chills
  • Onycholysis
  • Hepatic function abnormal
  • Sjogren's syndrome
  • Hepatitis cholestatic
  • Migraine
  • Blood urea increased
  • Gastrointestinal perforation
  • Eye pain
  • Skin discolouration
  • Intestinal ulcer
  • Abdominal pain upper
  • Discomfort
  • Ill-defined disorder
  • Myalgia
  • Musculoskeletal discomfort
  • Increased appetite
  • Proctalgia
  • Rectal tenesmus
  • Anorectal discomfort
  • Menometrorrhagia
  • Dermatitis bullous
  • Erectile dysfunction
  • Rectal haemorrhage
  • Photosensitivity reaction
  • Gastrointestinal disorder
  • Reaction gastrointestinal
  • Upper gastrointestinal symptoms
  • Affective disorder
  • Face oedema
  • Visual impairment
  • Erythema
  • Insomnia
  • Deafness
  • Hearing impaired

Indications

  • Ankylosing spondylitis
  • Arthralgia
  • Bursitis
  • Capsulitis
  • Contusion
  • Dysmenorrhoea
  • Fibromyalgia
  • Gout
  • Inflammation
  • Low back pain
  • Osteoarthritis
  • Osteoarthritis of cervical spine
  • Pain
  • Post-traumatic pain
  • Postoperative pain
  • Primary dysmenorrhea
  • Rheumatoid arthritis
  • Sciatica
  • Sports injury
  • Sprain
  • Swelling
  • Synovitis
  • Tendonitis

Subjective effects []

0xea / Ketoprofen []
Routes:
  • Oral
Effects:
emily / Ketoprofen []
Routes:
  • Oral (50mg)
Pilz / Ketoprofen []
Routes:
  • Oral (50mg)
Source:
  • Polish Pharmacy: Ketonal 50mg Capsules
Indication:Effects:Notes:

 []

  • Australia: Ketoprofen is a S3 / S4.
  • Canada: Ketoprofen is Prescription only.[3]
  • United States: Ketoprofen is Prescription only.
  • Other: Ketoprofen is a Rx-only & OTC.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3825, Ketoprofen. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3825
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ketoprofen. UNII: 90Y4QC304K. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/90Y4QC304K
  3. Health product highlights 2021: Annexes of products approved in 2021. Health Canada. 3 August 2022. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-product-highlights-2021/appendices.html

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 08:00:46
drugspromissing (no DrugsPRO reagent data)2026-11-20 08:00:42
erowidmissing (no Erowid substance of that name)2026-11-20 08:00:42
gsrsok2026-11-20 08:00:43
hmdbmissing (hmdb.ca refused automated access to HMDB0015144)2026-11-20 08:00:42
keggok2026-11-20 08:00:44
pubchemok2026-11-20 08:00:40
redditmissing (no r/tripreports posts mention it)2026-11-20 08:00:42
siderok2026-11-20 08:00:42
structureok2026-11-20 08:00:42
wikipediaok2026-11-20 08:00:42